Adicon Holdings Ltd

Company Profile

• Business description

  Founded in 2004 and listing on the Hong Kong Exchange in 2023, Adicon is one of the largest independent clinical laboratories in China. In October 2018, private equity Carlyle Group completed its investment in Adicon and has since been the largest single shareholder. Following Carlyle’s investment, Adicon quickly stepped up its footprint. It has a testing portfolio of over 4,000 medical diagnostic tests with 36 self-operated laboratories in 2023, compared with 1,800 items and 21 labs in 2018. Currently, esoteric tests account for nearly 60% of its testing portfolio. Esoteric tests require more specialized technologies and/or equipment.

• Contact

  No. 208, Zhenzhong Road
  West Lake
  Zhejiang
  Hangzhou
  CHN

  T: +86 57187779340

  https://www.adicon.com.cn

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Diagnostics & Research

  Fiscal Year End

  31 December 2025

  Employees

  5,456